For endorsement at the 21st AHWP Meeting-PROPOSED FINAL document on "Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) Devices for the Medical Device Manufacturer or Its Authorized Representative"

After consolidating the comments received from GHWP members by 18 Nov 2016, the PROPOSED document on "Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) Devices for the Medical Device Manufacturer or Its Authorized Representative" developed by GHWP WG4 has become the captured PROPOSED FINAL document, for the endorsement at the 21st GHWP Meeting in Cebu.

Download file

PROPOSED FINAL_Guidelines for adverse event reporting of PCI device_20161013.pdf